Canlyniadau Chwilio - Yassine Rechoum

  • Dangos 1 - 6 canlyniadau o 6
Mireinio'r Canlyniadau
  1. 1
    Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight

    Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight gan Suzanne A.W. Fuqua, Guowei Gu, Yassine Rechoum

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    The role of androgen receptor in breast cancer

    The role of androgen receptor in breast cancer gan Domenico Iacopetta, Yassine Rechoum, Suzanne A.W. Fuqua

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer

    The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer gan Sasha M. Pejerrey, Derek Dustin, Jin-Ah Kim, Guowei Gu, Yassine Rechoum, Suzanne A.W. Fuqua

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer

    Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer gan A. Ciupek, Yassine Rechoum, Guowei Gu, Luca Gelsomino, Amanda Beyer, Lauren Brusco, Kyle R. Covington, Anna Tsimelzon, Suzanne A.W. Fuqua

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    AR collaborates with ERα in aromatase inhibitor-resistant breast cancer

    AR collaborates with ERα in aromatase inhibitor-resistant breast cancer gan Yassine Rechoum, Daniela Rovito, Domenico Iacopetta, Ines Barone, Sebastiano Andò, Nancy L. Weigel, Bert W. O’Malley, Powel H. Brown, Suzanne A.W. Fuqua

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling

    ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling gan Luca Gelsomino, Guowei Gu, Yassine Rechoum, Amanda Beyer, Sasha M. Pejerrey, Anna Tsimelzon, Tao Wang, Kenneth E. Huffman, Andrew T. Ludlow, Sebastiano Andò, Suzanne A.W. Fuqua

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: